☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Decision
Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns
October 15, 2020
The US FDA Delays its Decision on Roche's Risdiplam for the Treatment of Spinal Muscular Atrophy
April 8, 2020
Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care
May 31, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
